Pharma Blog Watch

Amgen Epogen Suits (Patent Baristas)
In his entry, blogger Stephen Albainy-Jenei discusses the patent suit in which Amgen recently prevailed over Aventis and Transkaryotic Therapies, along with the long history of similar cases involving Amgen's erythropoietin hormone technology, Epogen.

Marketing Drugs to Physicians (Pharma Marketing Blog)
In his blog, John Mack writes about so-called precision marketing of drugs to physicians, which is the topic of an Aug. 15 article in the Annals of Internal Medicine, and relates it to what he calls buzz marketing.